Download PDFPDF
Sex: a major predictor of remission as measured by 28-joint Disease Activity Score (DAS28) in early rheumatoid arthritis?
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

  • Published on:
    Gender differences in remission rate shown by DAS28 criterion remained when applying ACR criteria

    Dear editor,

    We have with great interest read the letter by Mäkinen, Hannonen and Sokka in the July issue of the ARD, 2008 (1). The authors make the point that the sex differences in remission rates assessed by DAS28 in patients with early RA reported by us (2,3) may be spurious due to the fact that DAS 28 does not take into account gender differences in erythrocyte sedimentation rate (ESR). Consequently they propose tha...

    Show More
    Conflict of Interest:
    None declared.